Diagnostic criteria for primary osteoporosis: year 2012 revision.
about
Once-weekly teriparatide increases bone mineral density in the distal 1/10 radius, but not in the distal 1/3 radius.A missense single nucleotide polymorphism in the ALDH2 gene, rs671, is associated with hip fractureGenetic risk score based on the prevalence of vertebral fracture in Japanese women with osteoporosis.Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk.Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy.Strontium coating by electrochemical deposition improves implant osseointegration in osteopenic models.Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologicsMore than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery.Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese womenUnderweight Young Women Without Later Weight Gain Are at High Risk for Osteopenia After Midlife: The KOBE Study.High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.Implementation of personalized medicine for fracture risk assessment in osteoporosis.Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients.Genetic risk score based on the lifetime prevalence of femoral fracture in 924 consecutive autopsies of Japanese males.The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study.Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men.Number of osteoporotic sites as a modifying factor for bone mineral density.Artificial neural networks to predict future bone mineral density and bone loss rate in Japanese postmenopausal women.Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.Association between sarcopenia and low back pain in local residents prospective cohort study from the GAINA study.Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS).Risk of osteoporosis in elderly individuals attending a dental clinic.Osteoporosis is less frequent in endometrial cancer survivors with hypertriglyceridemia.Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.Panoramic radiography measurements, osteoporosis diagnoses and fractures in Japanese men and women.Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function.Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.Femoral osteoporosis is more common than lumbar osteoporosis in patients with Werner syndrome.The clinicopathologic findings of a subchondral insufficiency fracture of the femoral head in a male patient: a case report.Combined use of ibandronate and eldecalcitol in postmenopausal Japanese women with osteoporosis.Cortical Thickness Index of the Proximal Femur: A Radiographic Parameter for Preliminary Assessment of Bone Mineral Density and Osteoporosis Status in the Age 50 Years and Over Population.Effect of C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blind clinical trial
P2860
Q33646498-55A685A3-DFAE-4C3D-9B40-A409C200718BQ33673795-049CF4A1-4FF1-4B02-8508-08E28AF001F8Q33716910-9403D56A-FFE2-4988-AA55-97AD8FCB569DQ33841902-C0459819-C8FF-401E-BD10-FDF28956E2E0Q33890822-7D8975BE-AF3F-4A9D-A2DB-EFDD3A7D34E9Q33948822-6206EE02-59C8-4244-96C4-24992B090604Q34585346-64AFCED5-E983-4987-AE9B-EDB613AD97FEQ35173200-5772F95C-9C25-48DF-84A3-8B403E5A115FQ35792875-A9943698-AC34-4790-B775-CB2A90DF0F4AQ35909167-1EE98B2E-F691-4DB5-B5AC-59DABDAF2116Q36181886-19F8F128-31DF-4B52-B06F-1510A86E0937Q37372637-1A888087-A17A-4F4B-AAC5-D2B738CBA397Q37488814-151C4B22-7783-40D8-9D3A-BCAC494FD11BQ38790581-82B4E72A-F16B-49F6-ADC5-E67A02C21EEAQ38819859-E5DD39B2-BE8A-4B73-8153-ABDF9723C88BQ39013796-FD654A02-7B4A-4D7B-886E-702B5EC261B6Q40171095-A6B8A3C6-7A17-4939-9C74-CC054C125E57Q40506157-E0C4BC63-C31F-41BE-AF41-0483D06105CAQ40881729-ABEECE24-CA5E-4298-8684-F4A26B774151Q41495138-0AF84B00-E453-4301-AB6F-98AEF1A9BDFCQ41671797-71A89471-4E80-4E8A-81EC-35C0B38FA9F7Q45902958-1720D270-EFC5-46BF-B9C9-5A56B36DB63FQ47110800-0E45829A-4C8A-4987-AC7F-EFBD94FDA7DBQ47143299-5E31C355-CF19-4F97-B5EF-610C4A360411Q47673732-535D644D-A53B-49B9-8B67-F24CC3D13CB1Q47701411-04A75607-BBC0-4024-B580-4CBBDA915D28Q47906915-99786091-0014-459F-A73B-B9C857DF4DA8Q48062375-340392A4-6444-44B6-9D2B-B403A5285FA3Q48128891-D2C4F533-43AF-417B-8042-D30BD94FA332Q49804196-453DD83C-4C85-41F4-A059-35232A468BFFQ50643421-0B0F787E-0F22-47EC-9538-395411D02813Q51712265-CD4B76A6-A3D8-44F7-AEEE-6EDDBAE4A8BBQ51783721-7A0A74B6-BF00-4DF1-8DD5-FF40B2CF57B8Q52770435-A2297172-C67D-477B-9F60-4E14F76F0786Q52978937-1CB4B50D-AD62-41CF-AE49-0B10E7C120A7Q54205972-7C71DC5B-141C-4DF4-AE70-ACDBD71BDE69Q55129208-85DB6496-1175-4BC5-B134-3D517AB6A5BDQ58132286-A95FA471-E993-47B1-92FB-97D0609DEF5F
P2860
Diagnostic criteria for primary osteoporosis: year 2012 revision.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diagnostic criteria for primary osteoporosis: year 2012 revision.
@en
type
label
Diagnostic criteria for primary osteoporosis: year 2012 revision.
@en
prefLabel
Diagnostic criteria for primary osteoporosis: year 2012 revision.
@en
P2093
P2860
P1476
Diagnostic criteria for primary osteoporosis: year 2012 revision.
@en
P2093
Hiroaki Ohta
Hiroshi Hagino
Itsuo Gorai
Japanese Society for Bone and ...... teria for Primary Osteoporosis
Masao Fukunaga
Masataka Shiraki
Naoto Endo
Saeko Fujiwara
Satoshi Soen
Takayuki Hosoi
P2860
P2888
P304
P356
10.1007/S00774-013-0447-8
P577
2013-04-04T00:00:00Z